Military-Facebook/Twitter Psyops and more
Pentagon Psychological Operations
The Pentagon has ordered a sweeping audit of how it conducts clandestine information warfare after major social media companies identified and took offline fake accounts suspected of being run by the U.S. military in violation of the platforms’ rules.
Colin Kahl, the undersecretary of defense for policy, last week instructed the military commands that engage in psychological operations online to provide a full accounting of their activities by next month after the White House and some federal agencies expressed mounting concerns over the Defense Department’s attempted manipulation of audiences overseas, according to several defense and administration officials familiar with the matter.
The takedowns in recent years by Twitter and Facebook of more than 150 bogus personas and media sites created in the United States was disclosed last month by internet researchers Graphika and the Stanford Internet Observatory. While the researchers did not attribute the sham accounts to the U.S. military, two officials familiar with the matter said that U.S. Central Command is among those whose activities are facing scrutiny. Like others interviewed for this report, they spoke on the condition of anonymity to discuss sensitive military operations.
Although ostensibly to target foreign audiences they also know US audiences will be consumers of the propaganda.
2019-Under Trump and right before COVID DoD creates a new position, Principal Information Operation Advisor to conduct operations in the Information Environment (like Social Media)
https://www.congress.gov/116/crpt/hrpt333/CRPT-116hrpt333.pdf
So we know an “information” operation by the Military was being planned in 2019
What else was the Military up to?
A very interesting sub-stack article relating to the suppression of repurposed medicines (except Remdesivir) by the Defense Threat Reduction Agency (DTRA)
FORT BELVOIR, Va. - The COVID pandemic took the world by surprise. Researchers were left scrambling to devise a way to best mitigate the negative impact this disease has on global health. However, at the Defense Threat Reduction Agency (DTRA) it is common to operate in the “what if” space when it comes to potential biological threats. In fact, DTRA investments in technologies that detect, mitigate, or neutralize chemical and biological threats to the military and the nation date back more than 20 years.
“In late 2019, DTRA started a new program called Discovery of Medical Countermeasures Against Novel Entities (DOMANE) to address novel and emerging threats,” stated Dr. David Hone, Chief Scientist within the Vaccines and Therapeutics Division at DTRA. “Based on previous work, we decided DOMANE would not only focus on FDA-approved drugs but also combination therapeutics, as we believe that no single drug will be completely effective in treating new diseases. COVID-19 has provided us an opportunity to test our hypotheses using DOMANE.”
DOMANE provides rapid decision-making capabilities to identify FDA-approved drugs that will most likely be effective therapeutics for COVID-19. Repurposing candidate drugs from a pool about 7,500 FDA-approved drugs to advance an effective COVID-19 therapeutic allows for a more rapid response in developing a therapeutic regimen. The end-result is a response that modifies COVID-19 in treated patients and promotes a speedy recovery.
Veklury®, which is more commonly referred to as Remdesivir, is a ribonuclease inhibitor developed by Gilead Sciences. It delivers broad-spectrum antiviral activity and has proven to be a modestly effective therapeutic for the treatment of COVID-19. Originally developed as an Ebola Zaire countermeasure, this DTRA-funded inhibitor transitioned for more advanced testing due to promising pre-clinical trials. Remdesivir inhibits viral replication in a wide variety of pathogens and was one of the first therapeutics identified in the Defense Department for repurposing to treat COVID-19. In the summer of 2020, Remdesivir received authorization for emergency use only in COVID-19 patients with continued FDA oversight.
To complement the modest therapeutic effect of Remdesivir, DOMANE also identified Famotidine, a COVID-19 disease modifier from Johnson & Johnson; Pfizer’s Celecoxib, an anti-inflammatory product; and Merck’s Mectizan®, Ivermectin, an antiviral for clinical trials. To learn whether a combination of these FDA-approved drugs is more efficacious than current treatments, DTRA partnered with Quantum Leap Healthcare to conduct a clinical trial. This volunteer trial will evaluate drug combinations in COVID-19 patients who are having difficulty breathing.
DTRA also collaborated with Leidos to develop a new clinical trial prototype to evaluate new drug combinations in two clinical studies: one in COVID-19 patients who have symptoms but are still breathing without assistance and another in COVID-19 that are not displaying any symptoms.
“We believe that the evaluation of additional repurposed drugs in clinical trials will find a successful treatment option and will pave the road toward FDA-approval of a greatly improved therapeutic treatment for COVID-19 patients,” said Hone.
DTRA is committed to supporting global health biosecurity efforts through continued vaccine and therapeutic discovery actions to treat COVID-19, as well as the next biological threat the nation faces.
###
About DTRA:
The Defense Threat Reduction Agency enables the Department of Defense, the United States government, and international partners to counter and deter weapons of mass destruction and improvised threat networks. For more information, visit
https://www.dtra.mil
.
https://www.dvidshub.net/news/388359/dtras-therapeutic-arm-latches-fda-approved-and-affordable-drugs-covid-19-relief
Also, isn’t it interesting that Ivermectin did not make the cut in this special fancy DOMANE system?
Veklury®, which is more commonly referred to as Remdesivir, is a ribonuclease inhibitor developed by Gilead Sciences. It delivers broad-spectrum antiviral activity and has proven to be a modestly effective therapeutic for the treatment of COVID-19. Originally developed as an Ebola Zaire countermeasure, this DTRA-funded inhibitor transitioned for more advanced testing due to promising pre-clinical trials. Remdesivir inhibits viral replication in a wide variety of pathogens and was one of the first therapeutics identified in the Defense Department for repurposing to treat COVID-19. In the summer of 2020, Remdesivir received authorization for emergency use only in COVID-19 patients with continued FDA oversight.
Sage: Are you clocking this? “DTRA-funded inhibitor”?
Also, again for emphasis:
Remdesivir inhibits viral replication in a wide variety of pathogens and was one of the first therapeutics identified in the Defense Department for repurposing to treat COVID-19.
But DTRA did fund, per this article, and “latched on to”…Remdesivir.
Dr. Robert Malone had been conducting a study with U.S. government-sponsored research teams. Specifically, Malone was working alongside U.S. Defense Threat Reduction Agency (DTRA) consultants to carry out supercomputer-based analyses to identify existing FDA-approved drugs that may be useful against the novel coronavirus responsible for COVID-19.
From Robert Malone’s J’Accuse post:
“And not long after that I dropped off. Which is a shame, because the reason I was there was to help get our fully powered, innovative inpatient and outpatient trials of the repurposed drugs famotidine, celecoxib, and ivermectin launched under DoD/DTRA funding which I had worked so hard to get dedicated to this project.”
Is it odd that Doc Malone would not specifically call out DTRA and hammer them for this?
Kind of a giant elephant in the room to not acknowledge.
Many people like to lay the blame for COVID on Fauci, and he certainly had a prominent role. However, 60% of Faucis salary comes from his involvement in Biodefense which was given to him after the Anthrax Attacks. The DoD felt the research would best be funded by him under HHS rather than them since if DoD funded it directly it would be easier to make the case it was bioweapon research. Starting in 2004 Fauci wore 2 hats, overtly one with HHS, and covertly one with DoD. DoD and HHS became partners, and they both partnered with the Wuhan Institute of Virology as well as with US Virology Labs including Ralph Barics UNC
Ralph Baric is known as the Godfather of Corona Virus and worked on DTRA funded Remdesivir and mRNA Coronavirus Vaccines with DARPA funded Moderna (signed an agreement with Moderna in December 2019)
On DECEMBER 12, 2019 an agreement was signed (pg 105) that Dr. Ralph Baric of the University of North Carolina would receive “mRNA corona virus vaccine candidates developed and jointly-owned by NIAID and Moderna”@Rossana38510044 @ydeigin@BillyBosticksonhttps://t.co/taAbB9FIvp
— Dr. Lawrence Sellin (@LawrenceSellin) February 27, 2021
Maybe Rand Paul could call him up and hear his testimony.
Here is what the head of the Lancet Covid Commission -Jeffrey Sachs had to say recently
Information now held by the research team headed by EHA , as well as the communications of that research team with US research funding agencies, including NIH, USAID, DARPA, DTRA, and the Department of Homeland Security, could shed considerable light on the experiments undertaken by the US-funded research team and on the possible relationship, if any, between those experiments and the emergence of SARS-CoV-2.
We do not assert that laboratory manipulation was involved in the emergence of SARS-CoV-2, although it is apparent that it could have been. However, we do assert that there has been no independent and transparent scientific scrutiny to date of the full scope of the US-based evidence.
Much vital information still resides in China, in the laboratories, hospital samples, and early epidemiological information not yet available to the scientific community. Yet a US-based investigation need not wait—there is much to learn from the US institutions that were extensively involved in research that may have contributed to, or documented the emergence of, the SARS-CoV-2 virus.
Only an independent and transparent investigation, perhaps as a bipartisan Congressional inquiry, will reveal the information that is needed to enable a thorough scientific process of scrutiny and evaluation.
https://www.unz.com/runz/covid-and-the-political-bankruptcy-of-the-alternative-media/
Yet guys like Rand Paul and Robert Malone only speak of Fauci. Fauci is the fall guy and while a real Demon himself his main function is as a cover for the masterminds.
And where does Trump the Commander in Chief fit in? An awful lot of the COVID planning (Financial, Scientific, Operational) went on during his Administration. He either knew or he was an unwitting dupe. The White House Classified all COVID meetings involving HHS in January 2020 before the US recorded a single COVID death. His Operation Warp Speed was a Military Operation with HHS support and despite obvious concerns about safety due to skipping necessary safety tests he has no remorse and is quite proud of these shots.
Suppression of repurposed drugs and Lockdowns (which he extended) occurred on his watch.
Some say he understandably didn’t reign in Fauci as thousands of Americans died or were financially ruined because it would hurt his election chances? Are you kidding me?
I think Del Big-tree nails it here
https://thehighwire.com/watch/
For those short on time watch 4:40-8:50
(Well worth watching the whole show)
With respect, Del Bigtree has asserted that he is a "Medical Journalist", which is an actual college degree with courses to take and exams to complete, to be awarded a degree ...None of which he has completed.
I guess he's well-intentioned, but he shouldn't claim to be something he's not. It diminishes his credibility.